Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Bringing Antimicrobial Susceptibility Testing (AST) to the Community

Bringing Antimicrobial Susceptibility Testing (AST) to the Community

An interview with Dr. Ester Segal from the Technion (Israel Institute of Technology), discussing the development of a 2D silicon microarray that supports the growth of bacteria and fungi for rapid antimicrobial susceptibility testing (AST) in the community. Dr. Segal will present her work at Pittcon 2019. Interview conducted by Alina Shrourou.

What is rapid antimicrobial susceptibility testing (AST) and how is it used?

AST is a test that already exists, but unfortunately, it is mostly practiced in clinical laboratories in hospitals and to less extent at the community level. It is a very simple technique that allows physicians to discriminate between infections caused by drug-sensitive/or resistant bacteria and prescribe the appropriate antibiotic treatment needed for specific patients.

Traditional ASTJarun Ontakrai | Shutterstock

For this test, patients provide a urine or blood sample, which gets sent to a lab where bacteria are then isolated from it. Next, the bacteria are tested against a wide array of antibiotics to see whether they grow in the presence of the antibiotics. Using the AST results, doctors know to which antibiotics and what dosage the bacteria will respond well to.

Currently, this technology is generally found in main hospitals and is not widely used in the community. Rapid administration of the correct antibiotics not only saves lives but also reduce widespread overuse and misuse of antibiotics in clinics.  

What are the benefits of AST?

I am sure that we are all aware of the extent of the problem with antimicrobial resistance. It is expected that by the year 2050, antimicrobial resistance will be the number one cause of death worldwide. It is expected that more than 10 million people will die each year as a direct result of exposure to these superbugs.

Even now, the numbers are pretty scary. In Europe, about 25,000 deaths per year are directly related to acquired antimicrobial resistance. It is a huge problem in our society, especially for old people or people with compromised immune systems. When these individuals visit a hospital or even a centralized clinic, they really are at risk of acquiring such resistant bacteria.

Unfortunately, we do not have enough antibiotics in the pipeline. The development of new antibiotics is not evolving fast enough, compared with the pace at which bacteria acquire resistance, so the threat posed by superbugs is immense.

Regarding the benefits of AST, one advantage is that a patient is not exposed to an antibiotic that fails to combat the disease-causing bacteria. From the patient’s perspective, they will have a much faster recovery and much better prognosis. And from a community point of view, it will reduce the misuse and overuse antibiotics and consequently will slow down the development of new superbugs.

This is only one part of the solution to antimicrobial resistance. The approach is not just about one test or a new antibiotic, but a holistic approach that needs to be addressed globally. Rapid and affordable AST is just one approach to lowering exposure to antibiotics and obviously not the only solution to this very complicated problem.

Please outline your work involving the use of functionalized photonic 2D silicon microarrays for susceptibility testing.

Our AST system employs a silicon chip, similar in many aspects to chips found in our smartphones and computers with, a unique periodic structure. We create a structure on the silicon surface that serves two purposes.

Firstly, it makes the bacteria adhere to and colonize the surface. Secondly, the structure reflects the light in a very precise manner which allows us to track the bacteria on the just by analyzing the changes in reflected light. Therefore, we do not need sophisticated microscopes to observe the bacteria; we get the information about the bacteria just by analyzing the light that we collect from the surface.

AST on a 2D silicon chip

Why does the silicon array provide an ideal platform for testing bacterial and fungal species?

In general, bacteria like to reside on surfaces, but we need to provide them with the right conditions to relocate quickly. Therefore, both the structure of the silicon chip and chemistry of surface are important. This is at the heart of our technology − ensuring the bacteria will like the surface, interact with it and quickly reside on it.

Then, the bacteria on the chip are exposed to various antibiotics and we can learn about their response to the drug in less than two hours. While, conventional AST, practiced in the clinical labs, takes at least 8 hours and expensive equipment.

What information about the bacteria/fungi does the on-chip device provide?

Once you understand the concept of the measurement, it is pretty simple. We basically get growth curves of the bacteria on the chip when exposed to different antibiotics at various concentrations. Based on these growth curves, we can determine which antibiotics (and at what concentration) stops the bacteria from growing or kills the bacteria.  All this information is gathered from the chip within less than two hours.

What can we expect to take home from your talk at Pittcon 2019, titled “On-Chip Rapid Diagnostic Susceptibility Testing of Bacteria and Fungi from Clinical Samples”?

The ultimate goal of my lab is to make this technique translational into daily clinical practice.

Providing rapid AST results in a simple and affordable manner can save lives and hopefully minimize the rise of microbial resistance.

How do you think your test will help to tackle antibiotic resistance?

In Israel, Europe and the US, we rely on doctors to prescribe antibiotics and we don’t have access to antibiotics without a prescription. However, in many countries such as India, you can just go to a pharmacy or store and buy antibiotics whenever you feel sick, without needing a prescription. Therefore, it could be the case that while we are trying to fight the emergence and spread of superbugs in the western world, in these other countries, the fight is almost lost.

Hopefully, a cheap and simple AST test that can be used outside of a laboratory will allow population with limited access to medical care get proper antibiotics while reducing the misuse and overuse.

Fungi-on-a-chip

What are you most looking forward to at Pittcon 2019?

It is my first time at Pittcon, so I am really looking forward to participating in this event.  I started to do my homework in advance to see which presentations I would be able to attend.

I am really looking forward to the ACS Sensors session. It is a relatively new journal that is making a huge impact in the field of sensors and biosensors, so I am really looking forward to the talks in this session. I am also very excited about attending the talks being presented in honor of the different prize winners. It is going to be a fascinating conference.

Where can readers find more information?

About Dr. Ester Segal

Ester Segal headshot Dr. Segal is an Associate Professor of Biotechnology and Food Engineering at the Technion – Israel Institute of Technology. Her research focuses on the broad interface between materials science and biotechnology to address problems in medical diagnostics, food safety, and therapy.

Dr. Segal received her Ph.D. in Chemical Engineering from the Technion in 2004 and later trained at the University of California – San Diego, where she was a Rothschild postdoctoral fellow.

Dr. Segal has authored more than 80 peer-reviewed journal articles, reviews, book chapters, and patents. She has received numerous prestigious fellowships and prizes over the course of her career, most recently the 2019 Advances in Measurement Science Lectureship Award by the American Chemical Society.

Tagged with:

About author

Related Articles